[9] [12] Thyroid hormone replacement is generally well tolerated in individuals
Additionally, if you dont lose at least 34% of your body weight within 1216 weeks, your doctor may recommend discontinuing the treatment
Semaglutide vs other options Your clinician may discuss alternatives or complements: Tirzepatide, a dual GIP/GLP-1 agonist, for certain patients Metformin for insulin resistance and appetite control in specific cases Menopause hormone therapy or testosterone management, when clinically appropriate, to improve sleep, energy, and training consistency Sleep apnea evaluation when snoring, morning headaches, or daytime sleepiness are present Nutrition coaching to simplify meals and planning The right tool is the one that fits your biology and your life
The strategies for when tirzepatide results plateau translate well to maintenance challenges, as many of the underlying principles are the same
Brain health and cognition Emerging research suggests GLP-1 receptor agonists may have neuroprotective properties
Figure 3C), and HOMA-IR ( = 0.046, = 0.060